Huimin Wang - Jan 7, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Japan & Intercontinental
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Jan 7, 2022
Transactions value $: -$637,540
Form type: 4
Date filed: 1/7/2022, 05:06 PM
Previous filing: Dec 10, 2021
Next filing: Feb 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$138K	+6.35K	+6.48%	$21.76	104K	Jan 7, 2022	Direct	F1
transaction	EW	Common Stock	Sale	-$776K	-6.35K	-6.08%	$122.16	98K	Jan 7, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-6.35K	-50%	$0.00	6.35K	Jan 7, 2022	Common Stock	6.35K	$21.76	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.